Skip to content

The effective dose of ciprofol combined with sufentanil in laryngeal mask placement during hysteroscopy with the sequential method

The effective dose of ciprofol combined with sufentanil in laryngeal mask placement during hysteroscopy with the sequential method

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068598
Enrollment
Unknown
Registered
2023-02-24
Start date
2023-02-22
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia in hysteroscopic surgery

Interventions

Sponsors

Department of Anesthesiology, Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: ? Patients underwent hysteroscopy; ? Age between 18 and 55 years old; ? Body mass index (BMI) 18–30 kg/m2; ? American Society of Anesthesiologists Physical Status (ASA-PS) score of Grade I or II; ? Signed informed consent.

Exclusion criteria

Exclusion criteria: ? Those with serious diseases such as heart, brain and lung; ? Those with severe liver and kidney dysfunction; ? Those with a history of allergy to anaesthetic drugs related to this study, eggs, seafood and soy; ? Those with severe anemia not corrected before surgery; ? Those with acute upper respiratory tract infection, chronic lung disease, pneumonia; ? Those with expected difficult airway assessed by the anesthesiologist; ? Those with abnormal electrocardiograph; ? Those with a history of anesthesia accidents or drug abuse; ? Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
the placement of the laryngeal mask;

Secondary

MeasureTime frame
blood pressure;heart rate;additional dose of ciprofol;ciprofol addition times;spo2;recovery time;duration of operation;

Countries

China

Contacts

Public ContactLiu B

Department of Anesthesiology, Guangdong Second Provincial General Hospital

bingshangdebalei18@126.com13430350753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026